A clinic-updated digital twin for Parkinson’s disease progression: Governed Bayesian forecasting with uncertainty-gated reporting

Read full text Summarise with VIRAT
Authors: Ahmed Abdelmonem Hemedan, Vladimir Despotović, Taras Lukashiv, Kinza Rian, Sonja R. Jónsdóttir, Claire Pauly, Lukas Pavelka, Sibylle Béchet, Esther Ademola, Morgan V. Leonard, Luiz Ladeira, Petr V. Nazarov
+3 more Liesbet Geris, Venkata Satagopam, Rejko Krüger
Cited by: 0
References: 37

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Abstract Background Clinical digital twins hold considerable promise for forecasting disease progression, yet the question of when a model’s outputs should be withheld remains largely unaddressed. A predictive model qualifies as a governed reporting system only when it specifies the operational boundaries under which its outputs are reliable and enforces criteria for suppressing results that fall outside those bounds. Methods We present a governed Bayesian digital twin for multi-domain Parkinson’s disease (PD) progression, tracking motor function (MDS-UPDRS Part III), cognition (Montreal Cognitive Assessment, MoCA), and autonomic function (SCOPA-AUT). A monotone latent state-space model captures disease progression under four architectural constraints: non-decreasing latent severity, visit-triggered updating, full posterior uncertainty propagation, and non-causal scope. A six-rule confidence gate evaluates each forecast before release; when evidence is insufficient, the gate suppresses the output and returns a structured reason code. We evaluated the framework on the Parkinson’s Progression Markers Initiative (PPMI), a multicentre longitudinal observational study ( N =4,628 participants; 28,185 visits), using five-fold cross-validation with independent model refits, equity analysis, and coupling-topology sensitivity assessment. The framework is available at https://gitlab.com/ahmed.hemedan/symphony-dt , with a research prototype at https://symphony-dt.com/ . Results Predictive interval coverage at the 95% level ranged from 94% to 96% across all three endpoints, compared with 64–69% for linear mixed-effects baselines. The confidence gate released governed forecasts at 32.7% of visits under strict three-domain requirements, increasing to 48.1% under a validated partial-observation extension. Suppression was predominantly driven by incomplete clinical assessment (51.5%) rather than model uncertainty (0.2%), and operated equitably across sexes (Cramér’s V =0.049). Five of six cross-domain coupling parameters were identified from the data (sign probability ≥ 0.99; contraction ratios 0.19–0.35), with all cross-domain forecast correlations matching the directions predicted by the coupling topology. The framework’s own diagnostics localised two observation-model limitations, Prodromal motor heteroscedasticity and medication-burden sensitivity, to a single model layer and specified their resolution. Conclusions Governed silence, defined as the rule-based suppression of predictions when reliability conditions are not met, can be embedded in clinical prediction architecture, quantified as a pipeline output, and audited for equity. This work demonstrates the technical executability of governed digital twin architecture at cohort scale and provides a foundation for prospective deployment under routine clinical conditions.

Fields of Study & Subjects

Parkinson's Disease Mechanisms and Treatments Artificial Intelligence in Healthcare Machine Learning in Healthcare

Publication details

Journal / source
medRxiv
Publication date
22 March 2026
Language
EN
Document type
Preprint